)
Visual24 Oct 2025
The rise of Alphabet
TherapeuticsMD (TXMD) investor relations material
TherapeuticsMD Q2 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 2025 earnings summary12 Aug, 2025
Executive summary
Transitioned to a pharmaceutical royalty company in December 2022, collecting royalties from licensed products after divesting commercial operations.
Main revenue sources are royalties and milestone payments from Mayne Pharma and international partners for IMVEXXY, BIJUVA, ANNOVERA, and prenatal vitamins.
All former commercial operations are now classified as discontinued operations in financial statements.
Continues to evaluate strategic alternatives, including potential mergers, acquisitions, or asset sales.
Financial highlights
Q2 2025 license revenue was $952K–$1.0M, up $718K–$766K from Q2 2024; six-month revenue was $1.35M, up $798K year-over-year.
Q2 2025 net income was $545K–$551K ($0.05/share) versus a net loss of $1.05M–$1.09M ($0.09/share) in Q2 2024.
Six-month 2025 net loss was $102K, a significant improvement from a $1.82M loss in the same period of 2024.
Cash and equivalents at June 30, 2025 were $6.07M–$6.1M, up from $5.06M at year-end 2024.
Operating expenses for Q2 2025 were $1.65M, down 45.5% year-over-year, mainly due to prior year impairment charges.
Outlook and guidance
Substantial doubt exists about the ability to continue as a going concern for the next twelve months due to unresolved disputes, capital needs, and market uncertainty.
May pursue additional equity or debt financing; failure to secure funding could force curtailment or discontinuation of operations.
Actively exploring a range of strategic alternatives, with no set timetable or assurance of outcome.
Elaborate on strategic alternatives' shareholder value
What drives future license revenue growth?
What is the cash runway based on current burn rate?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next TherapeuticsMD earnings date
Q3 202511 Nov, 2025
Next TherapeuticsMD earnings date
Q3 202511 Nov, 2025
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
TherapeuticsMD Inc. is a pharmaceutical company specializing in the development and commercialization of products for women’s health. The company focuses on therapies addressing menopause, contraception, and prenatal health, offering prescription medications and hormone-based treatments. TherapeuticsMD’s portfolio includes products for hormone replacement therapy (HRT) designed to address symptoms of menopause and related conditions. The company is headquartered in Boca Raton, Florida, and its shares are listed on the NASDAQ.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage